60 Degrees Pharmaceuticals Reveals Q2 Performance Updates
60 Degrees Pharmaceuticals Reports Insights from Q2 2025 Recently, 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) has shared its financial results for the second quarter of 2025. This quarter experienced some interesting dynamics due to a supply disruption which impacted product revenues, yet ultimately resulted in higher profitability. The Company has showcased...
Continue Reading